Antares Pharma prices underwritten public offering of common stock

Antares Pharma, Inc. (NYSE Amex: AIS) today announced it has priced a firm commitment underwritten public offering of 12,500,000 shares of the Company's common stock at a purchase price of $1.60 per share for an aggregate gross offering amount of $20.0 million.

The offering is expected to close on or about May 18, 2011, subject to customary closing conditions. The Company has also granted the underwriter a 30-day option to purchase up to 1,875,000 shares of common stock to cover over-allotments, if any. Oppenheimer & Co. Inc. is acting as the sole bookrunner for the offering. ROTH Capital Partners and Ladenburg Thalmann Co. Inc. acted as financial advisers.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.